chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; Vomiting; Achy muscles and joints; Achy muscles and joints; I had no energy; This is a spontaneous report from a contactable consumer reported for self. A 58-year-old female patient (No pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 25Mar2021 12:30 PM (Lot Number: EP7534) as single dose for covid-19 immunisation. Medical history included lupus. The patient did not have covid prior vaccination, no covid tested post vaccination, and did not have Known allergies. Concomitant drug was reported as too many to list. The patient experienced nausea, vomiting, achy muscles and joints, and she had no energy on 25Mar2021 03:00 AM with outcome of not recovered. All events considered serious due to Disability or permanent damage. No treatment received for the events. This has lasted for 5 days as of this date.
Doses given from expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses given from expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses given from expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses given from expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  and treatment information was reported. Five doses were administered on 05-NOV-2021 and three doses were administered on 08-NOV-2021. There were 2 vials involved.
chills, aches began evening of 9/21/99 & cont through 9/23/99;lt arm became red, warm & swollen from shoulder to antecubital space-area measures 12cm x 13cm;area is tender to touch;
severe and disabling dizziness; This is a spontaneous report from a contactable consumer.  A 68-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6202) on 23Feb2021 at 16:00 at single dose via an unspecified route of administration on arm left for COVID-19 immunization. Relevant medical history included high blood pressure and myopia at -8.5. Concomitant medications included. On 24Feb2021 at 03:00 a.m. within 10 hours from vaccination, patient experienced severe and disabling dizziness. It was informed that events resulted in doctor visit. The events were longer persisting 5 days after vaccine with only minimal improvement. At the time of the reporting the patient had yet recovered from the events.
rash on the deltoid area; her deltoid turned red and Itchy/COVID arm; Itchy deltoid; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy deltoid), VACCINATION SITE RASH (rash on the deltoid area) and VACCINATION SITE ERYTHEMA (her deltoid turned red and Itchy/COVID arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy deltoid) and VACCINATION SITE ERYTHEMA (her deltoid turned red and Itchy/COVID arm). On an unknown date, the patient experienced VACCINATION SITE RASH (rash on the deltoid area). At the time of the report, VACCINATION SITE PRURITUS (Itchy deltoid) and VACCINATION SITE ERYTHEMA (her deltoid turned red and Itchy/COVID arm) had not resolved and VACCINATION SITE RASH (rash on the deltoid area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history and concomitant medications were provided. Treatment medication incldued Benadryl to alleviate the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Follow up received with updated "Patient demographics and the vaccine received date on 23JAN2021. 8 days after, deltoid turned red and itchy that last till today and reported it as "COVID arm".Consent YES to Follow up
I developed a rash under my chin and noticed it the next morning when I went to work - Friday Aug 13, 2021. I felt sick all weekend and noticed this rash was now going into my ear and on Sunday it was very painful - somewhat itchy, but very painful. Noticed it on my right side of face. I called my doctor Monday morning immediately and they wanted me to come into the office. She stated the rash looked like shingles and started me on valacyclovir 1000mg tablet and hydrocortisone cream 2.5 % cream. The rash finally went down towards the end of the week -friday, Saturday. I did notice a couple little spots show up on my right arm on Friday - but not sure it was related. My doctor said if it was to get worse to go to Urgent Care. I did also speak to a doctor from employee health today from the hospital and he said that my primary care doctor needs to send in a form stating I had an adverse reaction from the vaccination. My doctor is on a leave of absence right now so I am scheduled to see the Nurse Practitioner from Employee Health tomorrow - Aug 26. I figured this should be reported as I read an article from April 21, 2021 and the title was "Rash Horror Shingles could be new but rare side effect of Covid vaccine, docs discover."
Sleeping a lot; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleeping a lot) and PAIN IN EXTREMITY (Sore Arm) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, LOSARTAN, GABAPENTIN, METFORMIN, ZOLPIDEM and APIXABAN (ELIQUIS) for an unknown indication.    On 26-Jan-2021 at 4:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SOMNOLENCE (Sleeping a lot) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, SOMNOLENCE (Sleeping a lot) and PAIN IN EXTREMITY (Sore Arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information which shows a temporal association between the use of the mRNA-1273 and the reported events, a causal relationship with the events cannot be excluded.
"Bubble came off & turned to scab with redness & little white spots around it" " (R) arm muscle" -"upper arm."
p/vax pt went for child hlth screening nurse observed red blotches on trunk not raised;blotches noted 1hr p/vax;
Pt devel pain & an epicondylitis of the elbow following vax w/Hep B vax; No further details were provided;
Swelling and itching left thigh.  Treated with amoxicillin and Benadryl ~ 4/12, improving today.
No adverse event; Bivalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 13-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients).    No concomitant medication details was reported. No treatment medication details was reported.
HEADACHE, PAIN SCALE 4; PAIN RADIATING DOWN LEFT ARM, FINGERS TINGLING AND NUMB, HOT FLASHES
Patient with 2 Moderna COVID vaccinations who admitted with positive COVID test.  Provider discharge note below:  "Brief Summary of Hospital Stay: The patient is a 39 YO male with h/o rheumatoid arthritis, essential tremor, hearing loss, anxiety/depression admitted on 01/24 for worsening tremor, confusion, difficulty speaking for 5 days prior to admission.  Patient was worked up to evaluate for stroke but CT head and CT of the head and neck unremarkable and MRI negative for evidence of infarct or cause of patient's symptoms.  Patient incidentally tested positive for COVID on admission at 1/24 but was otherwise asymptomatic for COVID other than possibly the encephalopathy.  Urine drug screen on admission positive for marijuana and amphetamines.  Patient did admit to marijuana and methamphetamine use on 01/25 a.m. but then otherwise denied use during the rest of hospitalization.  Patient then became quite encephalopathic and agitated during hospitalization requiring aggressive use of Haldol and Ativan and Geodon with restraints before slowly improving to the point such that by time of discharge patient was fully alert oriented without hallucinations or psychosis.  Discontinued patient's hydroxychloroquine for now as this can also cause confusion hallucination although patient had dose on 01/26 without issue and more suspicious of use of amphetamines as cause of patient's encephalopathy.  Reviewed patient's medications with him and none of them appear to be candidates for causing a false positive test.  Given patient's complaint of tremor, did increase propranolol to 160 from 01/20 daily.  Discussed case briefly with Dr. of Psychiatry on 01/27 who advised close follow-up with the doctor whom patient typically follows with, an appointment has been made for 2/10.  On day of discharge patient was alert oriented and neurologically intact and without evidence of confusion and without SI or HI.   Issues Requiring Follow Up:  -follow-up with Psychiatry to evaluate if etiologies patient's confusion potentially could event Psychiatric although other causes including possible methamphetamine use appear to be more likely (versus less likely options such as the hydroxychloroquine and COVID infection) -follow-up with Rheumatology to evaluate potentially restarting hydroxychloroquine versus using another agent."
This spontaneous report as received from a 65 year old male patient with cardiovascular disorder (CV), as part of a marketing research program titled "HCC adult vaccine location journey" (Project #15-1340) conducted by the planning shop intl., refers to himself. On an unknown date, the patient was vaccinated with a dose of PENUMOVAX23 (dose, route and lot # unknown). Concomitant therapy was not reported. ON an unknown date the patient experienced soreness at injection site. The outcome of the event was recovered in February 2015. The patient also experienced soreness at injection site after vaccination of ZOSTAVAX, (captured in MARRS#1510USA09011). Additional information has been requested.
Pt. presented at hospital ED with cellulitis on 8/31/11. Was given IV antibiotics and KEFLEX. Went back this morning (9/1/11) for another abx treatment).
Rotator cuff soreness, pain and limited range of motion. Five sessions at physical therapist.
Cellulitis, erythema, swelling to left thigh s/p DTaP & IPV vaccinations administered 1/14/13. 1/17/13 Rx'd Cephalexin 250 mg/ml.
In order of occurrence: Chills Face and neck hot and itchy, red rash on face Back itchy, red rash across back Head itchy, can't tell if a rash Bad arm pain to touch, not usual shot arm pain, couldn't lay on left side to sleep Cold all night, used 2 blankets instead of usual 1; fitful sleep As if this writing: arm pain better but minor arm redness/swelling; face and neck hot; neck/back/head itchy, rash on neck/back but not as red as yesterday
covid arm x 1 week after first and second shot, started one week after injections and "knocked out" for 2 days after second vaccine.
Information has been received from a registered nurse concerning a 32 year old male employee who on 12/19/01 was vaccinated with the first dose of Varivax. On 01/01/02, the patient developed cold symptoms, and on 01/02/02, developed a red itchy rash on head, back and face. The patient sought unspecified medical attention. Additional information has been requested.
Had numbness and tingling bilaterally down arms to hands and fingers.  Also had tingling of face.  Presented with diarrhea around 9pm and then again at 9:30 pm.  Felt as if tongue was getting swollen but exam at 9:30 pm proved otherwise.
Patient experienced a rash that started on chest & spread out, but only lasted about 2 minutes.
Within 5-10 minutes of receiving injection, mom observed red rash on hands, within 20-30 minutes spread to right ear; no respiratory distress. Child playful and active.
Believes Wrong vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Believes Wrong vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Believes Wrong vaccine administered). At the time of the report, WRONG PRODUCT ADMINISTERED (Believes Wrong vaccine administered) had resolved.       Reporter did not allow further contact; Sender's Comments: This report refers to a case of wrong product administered for mRNA-1273, with no associated AEs.
01/04/2022 At first, I thought my asthma was getting worse, I was having trouble breathing. I was using my albuterol more. Then the headaches started. I called my neighbor and he had COVID-19. I did a COVID-19 test at my doctor's office and it was positive. He gave me a steroid, cough medicine and anti-nausea. I would get nauseated when I ate. I still have breathing issues. This lasted for about 6 weeks.
This spontaneous report as received from a registered nurse via a field employee refers to a male patient of unknown age. On an unspecified date about 8 years ago approximately in 2006 the patient's wife was vaccinated with a dose of ZOSTAVAX. On an unknown date after vaccination the husband broke out with chickenpox on his head. It was unknown if the patient sought medical attention. The outcome of the adverse event was unknown. Additional information has been requested.
Intense arm ache evening after the vaccination.  Woke the next morning with a splitting headache and fever.  Headache subsided after taking one Tylenol, but fever maintained through 03/10/2021.   It took 2 more days before it finally returned to normal.
Tinnitus both ears, saw ENT, cut back on sugar, caffeine, salt, sound therapy with Widex Zen tinnitus management. Still have tinnitus in both ears.
Low fever, chills, headache, dizziness, nausea. 28 hrs so far. Starting to feel better but still have headache and real tired
pt recv vax & devel inj site rxn characterized by redness & induration 48 to 72hr p/vax;pt also devel fever ranging from 103 to 104;this is one of six patients from this site w/the above rxn;
Headache Fever 100 Rash on both arms all the way to hand Rash on torso front and back ( does not itch) Taking Tylenol and Benadryl
Patient ran 6-10 miles daily and also hiked our neighboring mountains. In May, his stamina and ability started gradually failing. He was also in a community choir and couldn't understand why he couldn't get a good breath or hold notes out. By mid-May, he was concerned enough that he scheduled a dr appt for June. Since his mother had recently had a heart attack, he was concerned maybe it was his heart. On June 7, 2021, he met with the doctor, who did a lot of blood work as well. They thought maybe he had some virus or was run down. He had a persistent cough, too. Patient was a volunteer cross country coach as well and he usually could keep up with the kids, but wasn't able to.  By the end of the summer and into the xc season, he could barely walk across the parking lot without stopping. He had to forgo his weekend hikes because he could no longer hike more than a few minutes. The cough continued. It took several weeks, but he was able to get another dr appt on October 14, where the doctor did an electrocardiogram, which was normal. He referred him to a cardiologist. On October 28th, patient tried to do a treadmill stress test, but passed out. They scheduled him for an angiogram the next week. During that week, he could not stand more than a few minutes at a time. He could not carry the trash can the 20 feet to the garage. We tried to walk around the yard or down the street and he had to stop and catch his breath frequently.  By Oct. 30, he had pain in his back and abdomen. Starting Oct. 31, he could only stay awake a couple of hours and then he'd need to nap several hours.  We called the dr on Nov. 1 and in the afternoon they said he could come back in for blood work again. At that point we all thought he had a fast-growing cancer. That evening our daughter suggested we use the pulse oximeter. His heart rate wouldn't get below 100 and his oxygen wouldn't get into the 90s. I called the doctor on call for advice and he suggested we go to the ER. He was weak, had chest, back, and abdominal pain, a persistent cough, no stamina. We described the symptoms and they recognized it as PE. They did a CT scan and said his lungs were full of clots and there were parts of one lung that had died (infarcted). They gave him a shot of blood thinner, got him on oxygen, and admitted him to the hospital for observation. He was able to be released the next day, but needed to be on oxygen for a month and rest quite a bit. He will need to be on blood thinners the rest of his life.  He received the bivalent booster this fall without any complications. We believe he has made a full recovery. He finally contracted COVID in July of 2022 for the first time and was ill, but it wasn't severe. (I keep a daily journal and was able to go back and see symptoms and dates - sorry for all the details if not needed.)
It was reported that a 4 month old male patient received Tripedia, ActHIB and IPOL vaccination on 01/11/00. Reportedly within 48 hours after his vaccination the patient developed twitching of the head, neck, and right arm. The patient was seen by a pediatrician and admitted to the hospital on 01/14/00, by a neurologist for possible seizure disorder.
This spontaneous report as received from a nurse refers to a multiple number of patients (also reported as "a lot") of unknown age and gender. The patients' relevant medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with unspecified series of M-M-R II (therapy type, dose, dose number, intervals, anatomical location and route of administration were not reported). On unknown dates, after receiving M-M-R II the patients "were testing negative for titers of some of the antigens". The outcome of the event of was unknown. The relatedness between the event of and M-M-R II was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Lightheaded; feeling of fullness or engorgement in the left breast; a tingling pain; burning; subarachnoid bleed; mild headache, worst headache, throbbing headache with a pain level she said felt like a 20; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SUBARACHNOID HAEMORRHAGE (subarachnoid bleed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (mild headache, worst headache, throbbing headache with a pain level she said felt like a 20). On 14-Feb-2021, the patient experienced SUBARACHNOID HAEMORRHAGE (subarachnoid bleed) (seriousness criteria medically significant and life threatening), BREAST ENGORGEMENT (feeling of fullness or engorgement in the left breast), PARAESTHESIA (a tingling pain) and BURNING SENSATION (burning). On an unknown date, the patient experienced DIZZINESS (Lightheaded). On 23-Feb-2021, HEADACHE (mild headache, worst headache, throbbing headache with a pain level she said felt like a 20) had resolved. At the time of the report, SUBARACHNOID HAEMORRHAGE (subarachnoid bleed), BREAST ENGORGEMENT (feeling of fullness or engorgement in the left breast), PARAESTHESIA (a tingling pain) and BURNING SENSATION (burning) outcome was unknown and DIZZINESS (Lightheaded) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (BNT162B2), on 10Nov2021 as dose 2, single (Lot number: FG-3527) at the age of 54 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: PCN" (unspecified if ongoing), notes: known allergies: PCN. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received Paxlovid from 03Jun2022 to 08Jun2022 for the treatment of COVID-19. Rebound symptoms on 13Jun2022 after Paxlovid treatment was reported.
Jan.6 (1 day after) soreness on site.  January 10 ( 5days after) rash on the site but tolerable and small January 14 (9 days after) rashes getting bigger, Chlorpheniramine and Hydroxyzine used alternately. Appointments done with dermatologist and dematologist (allergist) January 16 . rash like a map spreading with swelling, induration, hot to touch, spreads to lowerarm . January 17 at 9 am. Video visit with NP: she said it look infected. Rx Augmentin.  8 pm: rashes untolerable itching, intense redness, spreading to both lower arms. eash on injection bigger and swollen, hot to touch, pain of 4. Meds given in ED: Diphenhydramine, Pepcid and Prednisone.